Flu Vaccine: Manufactures & Market Analysis
Over the recent years, the Influenza Vaccine market has witnessed double digit growth rate due to fear of an impending pandemic. The Influenza Vaccine market has grown at a CAGR of approximately 65% between 2008 and 2010 due to the havoc caused by H1N1 virus. However, H1N1 vaccine demand will decline due to waning threat of swine flu epidemic. The Influenza Vaccine market is expected to cross USD 4 billion in 2015. Among all the geographical regions, U.S. was the largest Influenza Vaccine market in the year 2010 closely followed by China. Top six players of influenza vaccine manufacturers occupy more than 75% of the total influenza vaccine market. Seasonal influenza vaccine brands like Fluarix & Flulaval were one of the leading players in the market in 2010. Other key players in this market include GlaxoSmithKline, Novartis, CSL, MedImmune, Sanofi-Pasteur, Solvay, Sinovac Biotech and Hualun Biologicals. Incase of Pediatric flu vaccine Starting in 2014-2015, CDC recommends use of the nasal spray vaccine (LAIV) for healthy children 2 through 8 years of age, when it is immediately available and if the child has no contraindications or precautions to that vaccine. Recent studies suggest that the nasal spray flu vaccine may work better than the flu shot in younger children.
- Case reports from vaccine manufacturers
- H1N1 vaccine and market analysis
- Pediatric flu vaccine and market analysis
- Respiratory flu vaccine and market analysis
- Bioprocess in influenza vaccine production
- Designing tools for influenza vaccine production
- Innovative vaccine manufacturing technologies using plant as bioreactor
Related Conference of Flu Vaccine: Manufactures & Market Analysis
8th International Conference on Infectious Diseases: Control and Prevention
11th International Conference on Infectious Diseases, Bacteriology and Antibiotics
14th Vaccines Research Development Conference
IV International Clinical Virology Symposium and Advances in Vaccines
World Vaccine Congress
The World Veterinary Vaccine Congress
Modern Vaccines Adjuvants Formulation
Options IX for the Control of Influenza
Incidence Severity and Impact of Influenza 2016
The North Central Avian Disease Conference
5th Anti-Virus Research Development
18th International Conference on Clinical Microbiology and Infectious Diseases
Flu Vaccine: Manufactures & Market Analysis Conference Speakers
Recommended Sessions
- Antivirals and Therapeutics
- Emerging Infectious Disease
- Entrepreneurs Investment Meet
- Epidemiology and Public Health of Influenza
- Flu Clinical Studies & Case Reports
- Flu Symptoms & Treatment
- Flu Vaccine: Manufactures & Market Analysis
- Flu Vaccines and Vaccination: Opportunities and Challenges for All Age Groups
- Flu Vaccines: Current and Novel Approach
- Flu Virus -Advancements in Detection & Differentiation
- Flu: Immunology & Genetics
- Laws and Ethical Issues Related to Flu Research
- Pathology of Influenza Virus Infections
- Surveillance Issues and Burden of Disease
Related Journals
Are you interested in
- A prospective study of dermatological infections - Emerging Infectious Diseases 2024 (France)
- Adrenal - Rare diseases 2024 (France)
- Advance therapies for rare diseases - Rare diseases 2024 (France)
- Antibiotics and Anti-viral - Euro Infectious Diseases 2024 (Italy)
- Antimicrobial Resistance - Emerging Infectious Diseases 2024 (France)
- Bacterial Infections - Euro Infectious Diseases 2024 (Italy)
- Bacterial Infectious Diseases - INFECTIOUS DISEASES-2024 (France)
- Bacterial, Viral, Fungal Infections - INFECTIOUS DISEASES CONF 2024 (Italy)
- Basic Virology - Virology 2024 (Italy)
- Cardiovascular diseases and Disorders - Emerging Infectious Diseases 2024 (France)
- Causes and Symptoms of Infectious Diseases - INFECTIOUS DISEASES-2024 (France)
- Changing patterns of infectious diseases - Emerging Infectious Diseases 2024 (France)
- Clinical and Case Reports - INFECTIOUS DISEASES CONF 2024 (Italy)
- Clinical and Case Reports - INFECTIOUS DISEASES-2024 (France)
- Clinical Management of Infectious Diseases - INFECTIOUS DISEASES-2024 (France)
- Clinical Virology - Virology 2024 (Italy)
- Covid-19 Infections - Infection Control 2024 (Italy)
- COVID-19, SARS & MERS - INFECTIOUS DISEASES CONF 2024 (Italy)
- Dental diseases & Infections - Emerging Infectious Diseases 2024 (France)
- Dermatological Infections - Euro Infectious Diseases 2024 (Italy)
- Diabetes and Wound Care - Emerging Infectious Diseases 2024 (France)
- Diagnostics and Laboratory Techniques - Emerging Infectious Diseases 2024 (France)
- Disinfection and Sterilization - Infection Control 2024 (Italy)
- Disorders of Calcium & Phosphate Homeostasis - Rare diseases 2024 (France)
- Drug Interaction in Infectious Diseases - INFECTIOUS DISEASES CONF 2024 (Italy)
- Emerging Infectious Diseases - Infection Control 2024 (Italy)
- Emerging Infectious Diseases & Recent Outbreaks - INFECTIOUS DISEASES CONF 2024 (Italy)
- Epidemiology and Public Health - INFECTIOUS DISEASES CONF 2024 (Italy)
- Epidemiology and Surveillance - Emerging Infectious Diseases 2024 (France)
- Food Borne & Water Borne Infections - INFECTIOUS DISEASES CONF 2024 (Italy)
- Fungal Infections - Euro Infectious Diseases 2024 (Italy)
- Fungal Infectious Diseases - INFECTIOUS DISEASES-2024 (France)
- Genetic disorders of Glucose & Insulin Homeostasis - Rare diseases 2024 (France)
- Genetic Endocrine Tumour Syndromes - Rare diseases 2024 (France)
- Global climatic change and emerging infectious diseases - Emerging Infectious Diseases 2024 (France)
- Global Health Security - Emerging Infectious Diseases 2024 (France)
- Global hotspots and correlates of emerging zoonotic diseases - Emerging Infectious Diseases 2024 (France)
- Growth & Genetic Obesity Syndromes - Rare diseases 2024 (France)
- Hepatitis Prevention - Infection Control 2024 (Italy)
- HIV Prevention, Treatment and Cure - Infection Control 2024 (Italy)
- Human Monkey pox: an emerging zoonosis - Emerging Infectious Diseases 2024 (France)
- Hypothalamic and Pituitary Conditions - Rare diseases 2024 (France)
- Immunological Rare Diseases - Rare diseases 2024 (France)
- Infection Control & Public Awareness - INFECTIOUS DISEASES CONF 2024 (Italy)
- Infection Control Bacteriology - Infection Control 2024 (Italy)
- Infection Control Business - Infection Control 2024 (Italy)
- Infection Control in Dental - Infection Control 2024 (Italy)
- Infection Control Precautions - Infection Control 2024 (Italy)
- Infection Control Treatment & Diagnosis - Infection Control 2024 (Italy)
- Infection Prevention and Control - Euro Infectious Diseases 2024 (Italy)
- Infection Treatment and Control - Infection Control 2024 (Italy)
- Infection, Immunity and Inflammation - INFECTIOUS DISEASES-2024 (France)
- Infectious Disease - Euro Infectious Diseases 2024 (Italy)
- Infectious Disease Pathology - Infection Control 2024 (Italy)
- Infectious Diseases - INFECTIOUS DISEASES-2024 (France)
- Infectious Diseases - Rare diseases 2024 (France)
- Infectious Diseases and Vaccines - INFECTIOUS DISEASES CONF 2024 (Italy)
- Infectious Diseases caused by Influenza virus - INFECTIOUS DISEASES CONF 2024 (Italy)
- Infectious Diseases Epidemiology - INFECTIOUS DISEASES-2024 (France)
- Infectious Diseases, Prevention & Control - INFECTIOUS DISEASES CONF 2024 (Italy)
- Influenza and Diagnostic Approaches - Infection Control 2024 (Italy)
- Internal Medicine for Infectious Diseases - INFECTIOUS DISEASES-2024 (France)
- Neuro Infectious Diseases - INFECTIOUS DISEASES-2024 (France)
- Neurological Infections - Euro Infectious Diseases 2024 (Italy)
- Nosocomial Infections & Control - Infection Control 2024 (Italy)
- Nosocomial Infections & Control - INFECTIOUS DISEASES-2024 (France)
- Nosocomial infections and their control strategies - Emerging Infectious Diseases 2024 (France)
- Nursing Infection Control - Infection Control 2024 (Italy)
- One Health Approaches to Virology - Virology 2024 (Italy)
- Ophthalmological Infections - Euro Infectious Diseases 2024 (Italy)
- Orphan Drugs - Rare diseases 2024 (France)
- Outbreak Investigation and Response - Emerging Infectious Diseases 2024 (France)
- Paediatric Infectious Diseases - Euro Infectious Diseases 2024 (Italy)
- Parasitic Infections - Euro Infectious Diseases 2024 (Italy)
- Parasitology & Infectious Diseases - INFECTIOUS DISEASES-2024 (France)
- Pathology and Microbiology - INFECTIOUS DISEASES CONF 2024 (Italy)
- Pediatric Infectious Diseases - Infection Control 2024 (Italy)
- Pediatric Infectious Diseases - INFECTIOUS DISEASES-2024 (France)
- Pediatric Infectious Diseases - INFECTIOUS DISEASES CONF 2024 (Italy)
- Perspectives on gastrointestinal infections - Emerging Infectious Diseases 2024 (France)
- Pharmacology of Infectious Diseases - INFECTIOUS DISEASES-2024 (France)
- Practical Guidelines - Infection Control 2024 (Italy)
- Practices & Awareness - Infection Control 2024 (Italy)
- Preventive Measures - Euro Infectious Diseases 2024 (Italy)
- Public Health - Euro Infectious Diseases 2024 (Italy)
- Public Health and Epidemiology - Virology 2024 (Italy)
- Public Health Policy and Preparedness - Emerging Infectious Diseases 2024 (France)
- Rare Autoimmune Diseases - Rare diseases 2024 (France)
- Research on Medicine and Vaccine for Covid-19 - INFECTIOUS DISEASES-2024 (France)
- Respiratory and Blood Infections - INFECTIOUS DISEASES CONF 2024 (Italy)
- Respiratory tract infections - Euro Infectious Diseases 2024 (Italy)
- Risk Factors & Prevention - Infection Control 2024 (Italy)
- SARS and MERS: recent insights into emerging coronavirus - Emerging Infectious Diseases 2024 (France)
- STD (Sexually Transmitted Diseases) and Control - INFECTIOUS DISEASES CONF 2024 (Italy)
- STD and HIV Infection - INFECTIOUS DISEASES-2024 (France)
- The Science of SARS-CoV-2 - Emerging Infectious Diseases 2024 (France)
- Therapeutics and Antiviral Agents - Virology 2024 (Italy)
- Therapeutics and Treatment Strategies - Emerging Infectious Diseases 2024 (France)
- Thyroid - Rare diseases 2024 (France)
- Treatment for Tuberculosis - Infection Control 2024 (Italy)
- Tropical Disease - Euro Infectious Diseases 2024 (Italy)
- Tropical Infectious Diseases - INFECTIOUS DISEASES-2024 (France)
- Urinary Tract Infection - Euro Infectious Diseases 2024 (Italy)
- Vaccine Research & Development - Infection Control 2024 (Italy)
- Vaccines - Euro Infectious Diseases 2024 (Italy)
- Vaccines and Immunization - Emerging Infectious Diseases 2024 (France)
- Vaccines and Vaccination - INFECTIOUS DISEASES-2024 (France)
- Vector-borne diseases: New Approaches to Control Vector from disease transmission - Emerging Infectious Diseases 2024 (France)
- Veterinary Diseases - INFECTIOUS DISEASES-2024 (France)
- Veterinary Infection Control - Infection Control 2024 (Italy)
- Viral Diagnostics and Laboratory Techniques - Virology 2024 (Italy)
- Viral Ecology and Evolution - Virology 2024 (Italy)
- Viral Genomics and Bioinformatics - Virology 2024 (Italy)
- Viral Infections - Euro Infectious Diseases 2024 (Italy)
- Viral Infectious Diseases - INFECTIOUS DISEASES-2024 (France)
- Viral Pathogenesis - Virology 2024 (Italy)
- Viral Vaccines and Immunology - Virology 2024 (Italy)